These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 35285869)

  • 1. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
    Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
    JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic ischemic lesions and presence of patent foramen ovale in young adults with embolic stroke of undetermined source: Results of the young ESUS patient registry.
    Meinel TR; Tsiplova K; Taylor A; Meseguer E; Haeusler KG; Hart RG; Arnold M; Perera KS
    Int J Stroke; 2024 Apr; 19(4):470-477. PubMed ID: 37981572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
    Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
    JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M
    JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ipsilateral Carotid Plaque Presence is Inversely Associated with Patent Foramen Ovale in Cryptogenic Stroke: A Multicenter CohortStudy.
    Sathya A; Nguyen TN; Reyes-Esteves S; Kamen S; Hester T; Vigilante N; Woo J; Zhang L; Abdalkader M; Cucchiara B; Siegler JE
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106606. PubMed ID: 35749935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From cryptogenic to ESUS: Toward precision medicine?
    Timsit S
    Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source.
    Nassif M; Annink ME; Yang H; Rettig T; Roos Y; van den Brink R; Tijssen J; Mulder B; de Winter RJ; Bouma BJ
    Int J Stroke; 2021 Jan; 16(1):7-11. PubMed ID: 31679479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
    Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
    J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
    Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
    J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Cryptogenic Stroke With Patent Foramen Ovale at Older Ages and Implications for Trials: A Population-Based Study and Systematic Review.
    Mazzucco S; Li L; Rothwell PM
    JAMA Neurol; 2020 Oct; 77(10):1279-1287. PubMed ID: 32628255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin: A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial.
    Merkler AE; Pearce LA; Kasner SE; Shoamanesh A; Birnbaum LA; Kamel H; Sheth KN; Sharma R
    JAMA Neurol; 2021 Dec; 78(12):1454-1460. PubMed ID: 34694346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
    Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source.
    Šaňák D; Divišová P; Hutyra M; Král M; Bártková A; Zapletalová J; Látal J; Dorňák T; Hudec Š; Franc D; Polidar P; Veverka T; Kaňovský P
    J Neurol Sci; 2020 Sep; 416():116985. PubMed ID: 32563078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
    Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
    BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
    Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
    Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Atrial Fibrillation Development in Patients With Embolic Stroke of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
    Bahit MC; Sacco RL; Easton JD; Meyerhoff J; Cronin L; Kleine E; Grauer C; Brueckmann M; Diener HC; Lopes RD; Brainin M; Lyrer P; Wachter R; Segura T; Granger CB;
    Circulation; 2021 Nov; 144(22):1738-1746. PubMed ID: 34649459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.